以人工智能药物发现为核心技术引擎,惠泰生物依托自主核心算法与全球知识产权布局,精准靶向纤维化疾病领域未被满足的临床刚需,开展源头创新药物研发与全链条商业化开发,攻坚抗衰老领域世界性临床难题。目前,公司人工智能辅助开发的药物已批准进入关键性临床试验阶段。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows